baber/WOPTO huggingface dataset:
Patent BR-PI1106315-B1 (BR)
Title: compósitos opticamente transparentes baseados em celulose bacteriana e boehmita, siloxano e/ou sistema boehmita, siloxano e processo de obtenção dos compósitos
Inventor: HERNANE DA SILVA BARUD
IPC: C08L1/02
Filed: 2011-01-28
Abstract: COMPÓSITOS OPTICAMENTE TRANSPARENTES BASEADOS EM CELULOSE BACTERIANA E BOEHMITA, SILOXANO E/OU SISTEMA BOEHMITA-SILOXANO. A presente invenção compreende compósitos com características multifuncionais, podendo substituir, com vantagens expressivas, principalmente a flexibilidade, o vidro em vários aplicativos, como, por exemplo, telas displays e outros. Dentre outros aspectos, o produto objeto da invenção se destaca por tornar celulose bacteriana transparente, além de ser flexível, biocompatível e substituir o vidro em 100% dos aplicativos. Dentre outros aspectos o desenvolvimento dos compósitos da invenção possibilita um aumento eficaz na transmissão óptica, tornando a transparência óptica superior a 90%, transparência essa necessária, analogamente, para o desenvolvimento de dispositivos médicos, por exemplo.
Patent EA-001042-B1 (EA)
Title: Fungicide mixtures
Inventor: BAYER HERBERT
IPC: A01N37/52
Filed: 1997-04-22
Abstract: 1. A fungicidal mixture comprising  a) an oxime ether of the formula I    where the substituents have the following meanings: X is oxygen or amino (NH); Y is CH or N; Z is oxygen, sulfur, amino (NH) or C1-C4-alkylamino (N- C1-C4-alkyl); R' is C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl, C3-C6-cycloalkylmethyl, or is benzyl which can be partially or fully halogenated and/or can have attached to it one to three of the following radicals: cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy and C1-C4-alkylthio; and/or b) a carbamate of the formula II,   where T is CH or N, n is 0, 1 or 2 and R is halogen, C1-C4-alkyl or C1-C4-haloalkyl, it being possible for the radicals R to be different when n is 2, and  c) (+-)-(2-chlorophenyl)(4-chlorophenyl)(pyrimidin-5-yl)-methanol III   in a synergistically active amount. 2. A fungicidal mixture as claimed in claim 1 wherein the weight ratio of the compounds I and/or II to the compound III is 10:1 to 0.1:1. 3. A method of controlling harmful fungi, which comprises treating the harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from them with a compound of the formula I and/or II as set forth in claim 1 and the compound of the formula III as set forth in claim 1 in a synergistically active amount. 4. A method as claimed in claim 3, wherein a compound I and/or II as set forth in claim 1 and the compound III as set forth in claim 1 are applied simultaneously together or separately or in succession. 5. A method as claimed in claim 3, wherein the harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from them are treated with from 0.005 to 0.5 kg/ha of a compound I and/or II as set forth in claim 1. 6. A method as claimed in claim 3, wherein the harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from them are treated with from 0.05 to 0.5 kg/ha of the compound III as set forth in claim 1. 7. The use of the compounds I and/or II as set forth in claim 1 for the preparation of fungicidally active synergistic mixtures as claimed in claim 1. 8. The use of the compound III as set forth in claim 1 for the preparation of fungicidally active synergistic mixtures as claimed in claim 1.
Patent EA-006648-B1 (EA)
Title: Methods for modulating the activity of a multiple lineage kinase protein comprising compound screening which modulate multiple lineage kinase protein
Inventor: MARONEY ANNA
IPC: C12Q1/02
Filed: 1999-08-18
Abstract: Methods for identifying compounds which modulate activity of a multiple lineage kinase protein and promotes cell survival or cell death comprising the steps of contacting the cell containing the multiple lineage kinase protein with the compound, determining whether the compound decreases activity of the multiple lineage kinase protein, and determining whether the compound promotes cell survival are provided. Methods for identifying compounds which may be useful in the treatment of neurodegenerative disorders and/or inflammation are also provided. Methods for modulating the activity of a multiple lineage kinase protein comprising contacting the protein or a cell containing the protein with an indeno- or indolo- compound of the invention are also provided.
Patent EA-005377-B1 (EA)
Title: TETRAHYDROIMIDAZO[1,2-h][1,7]NAPHTHYRIDINE COMPOUNDS
Inventor: POSTIUS STEFAN
IPC: C07D471/14
Filed: 1999-09-17
Abstract: Compounds of formula (I) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
Patent EA-008141-B1 (EA)
Title: Process for making amlodipine maleate
Inventor: PICHA FRANTISEK
IPC: A61P9/12
Filed: 2001-08-15
Abstract: A process for making amlodipine maleate comprises reacting amlodipine or an acid addition salt thereof with maleic acid under an acidic environment to form an amlodipine maleate product. The process allows for the formation of amlodipine maleate substantially free from amlodipine aspartate.
Patent EA-010840-B1 (EA)
Title: Process for preparing caprolactam by beckmann rearrangement
Inventor: SMEETS THEODORUS MARIA
IPC: C07D201/04
Filed: 2004-05-17
Abstract: The invention relates to a process for preparing caprolactam by Beckmann rearrangement of cyclohexanone oxime by feeding cyclohexanone oxime to a reaction mixture comprising (i) sulfuric acid (ii) SO3 and (iii) caprolactam, wherein the SO3 content of the reaction mixture is between 9 and 20 wt.% and the molar ratio M of the reaction mixture defined as (n+ n)/nis between 1 and 1.4,wherein n= quantity of SOin reaction mixture, in mol,n= quantity of HSOin reaction mixture, in mol,n= quantity of caprolactam in reaction mixture, in mol.
Patent EA-016485-B1 (EA)
Title: Processes for preparing 3-benzazepines
Inventor: BURBAUM BEVERLY W
IPC: A61K31/55
Filed: 2004-06-16
Abstract: The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
Patent EA-008093-B1 (EA)
Title: Integrated system for aircraft vortex safety
Inventor: BARANOV NIKOLAI ALEXEEVICH
IPC: G01S13/93
Filed: 2003-07-25
Abstract: The invention relates to systems for preventing off-normal situations when there is a possibility that an aircraft penetrates into a dangerous area of the vortex shedding of a vortex generator. The inventive system consists of information sub-systems for recording and storing information on the expected relative position of the aircraft and trailing vortex areas in line with danger criteria which are specified by a user and concern dangerous aerodynamic forces and torques effecting the aircraft and induced by the trailing vortex of vortex generators, and for conveying said information to said user, who can be the aircraft crew and/or flight attendants, at a preventive distance from the aircraft and at a forecast moment. Said information can be visualised in a human-readable form and in a volume sufficient for forming a directive signal for carrying out a flight manoeuvre by the aircraft in order to move away from the dangerous trailing vortex area.
Patent EA-009897-B1 (EA)
Title: Use of polypeptides of the cupredoxin family in cancer therapy
Inventor: CHAKRABARTY AMANDA M
IPC: A61P35/00
Filed: 2004-08-10
Abstract: Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The invention also relates to methods for identifying active agents useful in treating conditions related to cell death or uncontrolled growth. The present inventors have found that different microorganisms produce different cytotoxic factor(s) having anticancer activity. The substantially pure cytotoxic factors can be used in a method of treating an infectious disease or a cancer.
Patent EA-010529-B1 (EA)
Title: Device and method for pneumatically conveying bulk materials in a dense flow method
Inventor: ERNST PATRIK
IPC: B65G53/52
Filed: 2005-07-22
Abstract: The invention relates to a device for pneumatically conveying a free-flowing bulk material in a dense flow method, containing a cross-sectionally closed conveying line (3) with a conveying channel (2), a compressed gas auxiliary line (4) with a compressed gas channel (18), and means (5) which permit the passage of compressed gas and which serve to supply the conveying channel (2) with a compressed gas from the compressed gas channel (18). The invention is characterized in that a fluidizing device is assigned to the conveying line (3), and the fluidizing device contains a fluidizing body (6) having a fluidizing gas channel (8) and means (9) which permit the passage of fluidizing gas and which serve to supply a fluidizing gas from the fluidizing gas channel (8) and into the conveying channel (2).
Patent EA-010863-B1 (EA)
Title: Selection of host cells expressing protein at high levels
Inventor: OTTE ARIE PETER
IPC: C12N15/67
Filed: 2005-11-07
Abstract: The invention provides a DNA molecule comprising a 5' multicistronic transcription unit coding for i) a selectable marker polypeptide functional in a eukaryotic host cell, and for ii) a polypeptide of interest, the polypeptide of interest having a translation initiation sequence separate from that of the selectable 10 marker polypeptide, characterized in that the coding sequence for the polypeptide of interest is downstream from the coding sequence for the selectable marker in said multicistronic transcription unit, and the nucleic acid sequence coding for the selectable marker polypeptide comprises a mutation that decreases the translation efficiency of the selectable marker in a eukaryotic host cell. The invention also provides methods for obtaining host cells expressing a polypeptide of interest, said host cells comprising the DNA molecules of the invention. The invention further provides the production of polypeptides of interest, comprising culturing host cells comprising the DNA molecules according to the invention.
Patent EA-011493-B1 (EA)
Title: Method and apparatus for building images using an induction logging method in oil based mud
Inventor: TABAROVSKY LEONTY A
IPC: G01V3/38
Filed: 2005-12-16
Abstract: An induction logging tool having transmitter and receiver antennas is used to make measurements of earth formations. The antennas may be mounted on the mandrel of a bottomhole assembly for MWD applications, or may be pad mounted for wireline applications. The induction measurements are inverted using a linearized model. The model parameters are determined in part from caliper measurements.
Patent EA-018983-B1 (EA)
Title: Method for increasing mobilization of migration of hematopoietic stem cells, method for producing a hsc population and methods of treating a disease using same
Inventor: SHAKHOV ALEXANDER
IPC: A61K38/08
Filed: 2008-01-09
Abstract: A method is provided for increasing the number of hematopoietic stem cells in the bone marrow, increasing the mobilization of these cells to migrate from the bone marrow to the bloodstream and elsewhere, and increasing the number of differentiating hematopoietic stem cells in the bloodstream.
Patent EA-020045-B1 (EA)
Title: Combination therapy with a compound acting as a platelet adp receptor inhibitor
Inventor: CONLEY PAMELA B
IPC: A61K31/235
Filed: 2008-05-02
Abstract: The present invention relates to pharmaceutical compositions and methods of using combination therapy comprising using [4-(6-fluoro-7-methylamino-2,4-dioxo-l,4-dihydro-2H-quinazolin-3-yl)phenyl]-5-chlorothiophen-2-ylsulfonylurea, or a pharmaceutically acceptable salt thereof and a second therapeutic agent selected from an anticoagulant agent, such as an anti-factor XI antibody and betrixaban, or a pharmaceutically acceptable salt thereof, an antiplatelet agent such as ifetroban or a combination thereof for the treatment of thrombosis diseases.
Patent EA-016209-B1 (EA)
Title: Process for the recovery of carbon dioxide from a gas stream
Inventor: OUIMET MICHAEL A
IPC: C01B32/50
Filed: 2007-12-14
Abstract: A process for removing acid gas from a gas stream utilizes a low viscosity absorbent comprising a solution of at least one selected amine.
Patent EA-015355-B1 (EA)
Title: Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
Inventor: DELAY-GOYET PHILIPPE
IPC: A61K31/444
Filed: 2008-04-16
Abstract: The invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the preparation of a medicament for use in the treatment of spinal cord traumas.
Patent EA-016068-B1 (EA)
Title: Cable-type electromagnetic receiver system for subsurface exploration
Inventor: DAVIDSON PER ANDERS
IPC: G01V3/12
Filed: 2008-06-23
Abstract: A marine electromagnetic survey cable includes a reference electrode extending substantially along the entire length of the cable. A plurality of spaced apart measuring electrodes is disposed along the cable and each is electrically insulated from the reference electrode. A voltage measuring is circuit functionally coupled between each measuring electrode and the reference electrode.
Patent EA-018582-B1 (EA)
Title: Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine hreceptor
Inventor: LETAVIC MICHAEL A
IPC: A61K31/495
Filed: 2008-11-17
Abstract: Certain cycloalkyloxy- and heterocycloalkyloxypyridine compounds of formula (I) are histamine Hreceptor modulators useful in the treatment of histamine Hreceptor-mediated diseases.
Patent EA-016672-B1 (EA)
Title: Method for production of calcium compounds
Inventor: BUSETH TORFINN
IPC: C01F11/24
Filed: 2009-01-07
Abstract: The present invention relates to a method for production of calcium compounds having very low content of phosphorus and boron from an impure calcium chloride, solution containing phosphorus and boron, which method comprises the following steps: a) addition of a FeCl3-solution to the calcium chloride solution, b) adjusting the pH of the solution by addition of a base to between 3 and 9.5 for precipitation of iron hydroxide, iron phosphate and boron compounds, c) removal of the solid precipitate from the solution in step b) obtaining a purified calcium chloride solution, d) precipitation of a calcium compound from the solution from step c), and e) separation of the calcium compound from the solution in step d).
Patent EA-022009-B1 (EA)
Title: Floor profile arrangement
Inventor: SONDERMANN FRANK
IPC: E04F19/06
Filed: 2010-06-10
Abstract: The invention relates to a floor profile arrangement, particularly for laying floor coverings (10), comprising at least one profile strip (1) comprising at least one retaining device (2) by which a first partial segment (4) of a connecting means (15) is retained, wherein a second partial segment (14) of the connecting means (15) protrudes past an edge area (5) of the profile strip (1) in the longitudinal axis (L) for connecting to a further profile strip (1).
Patent EA-021317-B1 (EA)
Title: Monolayer tablets comprising irbesartan and amlodipine, their preparation and their therapeutic application
Inventor: KHULLAR PRAVEEN
IPC: A61P9/12
Filed: 2009-09-17
Abstract: The present invention is directed to solid monolayer tablets comprising irbesartan, amlodipine besilate and pharmaceutically acceptable excipients, to their preparation and to their therapeutic application.
Patent EA-028227-B1 (EA)
Title: Stabilized formulations containing antibodies to human proprotein convertase subtilisin/kexin type 9 (pcsk9)
Inventor: WALSH SCOTT
IPC: C07K16/40
Filed: 2012-07-27
Abstract: The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human proprotein convertase subtilisin/kexin type 9 (PCSK9). The formulations may contain, in addition to an anti-PCSK9 antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
Patent EA-028090-B1 (EA)
Title: Device for mixing and grinding
Inventor: AFANASIEV ALEKSEY GAVRIILOVICH
IPC: B22C5/04
Filed: 2015-05-13
Abstract: The claimed invention is related to mechanical engineering, in particular, to equipment used for dry and wet grinding of lump, grain and powder materials, and for preparation of mixtures. The technical result of the present invention includes higher productivity of the grinding and mixing process, shorter duration of the processing cycle, and higher dispersion (fineness) of ground material. The technical result is achieved by provision of a mixing and grinding device comprising a working container with a bottom and a lid connected to a rotation drive mounted on a frame, wherein the working container is mounted on a shaft carrying, inside the working container, at least one bracket with at least one blade having a cutting edge, a front and back surfaces; the at least one blade mounted on at least one bracket has through slots and/or holes extending from the front to the back surface, the smallest width of the slots and/or holes in the cross-section transverse to their longitudinal axis is less than the smallest size of the grinding bodies. The longitudinal axes of the through slots are disposed in planes transverse to the axis of rotation of the working container. The distance between longitudinal axes of the through slots and/or holes is greater than or equal to the largest size of the grinding bodies. The front surface of the blade has grooves in front of the holes and behind the through slots and/or holes, the axes of the grooves being an extension of the longitudinal axes of the through slots and/or holes. The grooves have the same shape as the shape of the through slot and/or hole in the cross-section transverse to their longitudinal axis, and a depth equal to or greater than the depth of penetration of grinding bodies into through slot and/or hole. The back surface of the blade has grooves behind through slots and/or holes, the groove bottom having a concave curvilinear shape in the longitudinal section of the grooves whose axis is extension of the axis of the through slots and/or holes. The through slots and/or holes have, in the section transverse to their longitudinal axis, a shape of, e.g., a rectangular, a parallelogram, a trapezoid, or X-like and Y-like shapes. The shaft with mounted brackets and blades is linked to the rotation drive by means of a self-braking transmission, and/or is connected to a brake.
Patent EA-036615-B1 (EA)
Title: Use of facilitates chromatin transcription complex (fact) in cancer
Inventor: GUROVA KATERINA
IPC: G01N33/574
Filed: 2014-02-11
Abstract: The present invention relates to, inter alia, measuring of at least one component of the facilitates chromatin transcription complex (FACT) for evaluating a tumor, including, for example, determining the aggressiveness of a tumor and directing treatment.
Patent EA-028247-B1 (EA)
Title: Method for closing an end part of a heating radiator element and aluminium radiator element
Inventor: NIBOLI ORLANDO
IPC: B23K11/18
Filed: 2014-03-25
Abstract: In accordance with the invention, a body (2) of an aluminium heating radiator element (1), comprising a substantially tubular end part (6) provided with a bottom opening (8), is closed by a cap (20) via a thermo-electric melting process; the end part (6) and the cap (20) are provided with respective melting portions (21, 22) having respective contact edges (23, 24) which are substantially equal in shape and dimensions, so as to reach the melting state at the same time during the thermo-electric melting process.
Patent EA-029312-B1 (EA)
Title: Imidazopyrrolidinone derivatives and their use in the treatment of diseases
Inventor: BLANK JUTTA
IPC: C07D487/04
Filed: 2014-05-26
Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, a method for manufacturing the compounds of the invention, and therapeutic uses thereof. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Patent EA-035975-B1 (EA)
Title: Method and formulation for treating hair when bleaching or coloring
Inventor: PRESSLY ERIC D
IPC: A61Q5/10
Filed: 2014-08-01
Abstract: Formulations, kits, and methods for treating hair when bleaching or coloring, in particular, for repairing disulfide bonds in hair are disclosed. Said formulations provide improved conditioning benefit for dry hair and a long lasting moisturized feel and smooth feel to hair, without feeling greasy. Said formulations comprise a binding agent of Formula Iwherein A, B, C, D, R, n, p, q, r and s are as defined in the claims. For example, the binding agent may be
Patent EA-036270-B1 (EA)
Title: Satellite communications subsystem in-orbit verification system and methodologies
Inventor: REID STEPHEN
IPC: H04B17/40
Filed: 2016-11-28
Abstract: The present invention relates to satellite systems and, more particularly, to the provision of novel systems and methods for verifying the in-orbit performance and operation of satellite communications subsystems. In contrast to traditional Payload IOT (in-orbit test), the invention operates without an uplink signal, by generating hardware-specific signatures using isolated, internally generated, thermal noise. It has been found that this noise provides a very stable, repeatable signal for testing. Prior to launch, a repeater command sequence is executed to generate a hardware-specific signature based on the internally-generated noise. The same repeater command sequence is then executed in-orbit to determine whether the hardware-specific signature has changed. The two signatures may be recorded and compared using a simple tool such as a spectrum analyzer. The methods also include novel use of the sun as a test signal source to calibrate equipment, to quantify atmospheric effects and to be used as an intermediate reference power level during measurements.
Patent ES-2197780-B1 (ES)
Title: Tubular continuo de malla para la formacion de bolsas para productos hortofruticolas y similares.
Inventor: ALTIMIRA FONTCUBERTA JUAN
IPC: B65D33/02
Filed: 2001-11-23
Granted: 2005-03-16
Abstract: Tubular continuo de malla para la formación de bolsas para productos hortofrutícolas y similares, cuyo tubular (1) está dotado de al menos un par de bandas laminares longitudinales de plástico que discurren a lo largo de la pared tubular, una (2a) por dentro y otra (2b) por fuera, en posiciones coincidentes y unidas entre sí para fijar entre ambas la estructura de la franja de malla que queda situada entre dichas bandas.